|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Clinical characteristics of Caroli's syndrome显示文摘Caroli's syndrome is characterized by multiple segmental cystic or saccular dilatations of intrahepatic bile ducts associated with congenital hepatic fibrosis. The clinical features of this syndrome reflect both the characteristics of congenital hepatic fibrosis such as portal hypertension and that of Caroli's disease named as recurrent cholangitis and cholelithiasis. The diagnosis depends on both histology and imaging methods which can show the communication between the sacculi and the bile ducts. Treatment consists of symptomatic treatment of cholangitis attacks by antibiotics, some endoscopic, radiological and surgical drainage procedures and surgery. Liver transplantation seems the ultimate treatment for this disease. Prognosis is fairly good unless recurrent cholangitis and renal failure develops. | Ozlem Yonem Yusuf Bayraktar | 2007 | World Journal of Gastroenterology2007，13，13： | 22 |
| 2 | Clinical characteristics of Caroli’s disease显示文摘Caroli's disease is a rare congenital condition chara- cterized by non-obstructive saccular or fusiform dilatation of larger intrahepatic bile ducts. Cholangitis, liver cirrhosis, and cholangiocarcinoma are its potential complications. The diagnosis of Caroli's disease depends on demonstrating that the cystic lesions are in continuity with the biliary tree which can be showed by ultrasonography, computerized tomography, endoscopic retrograde cholangiopancreatography, percutaneous transhepatic cholangiography or magnetic resonance cholangiopancreatography. Treatment of Caroli's disease relies on the location of the biliary abnormalities. While localized forms confined to one lobe can be treated with surgery, liver transplantation is the only effective modality for diffuse forms. Although a rare disorder; Caroli's disease should always be considered in the differential diagnosis of chronic cholestasis of unknown cause. | Ozlem Yonem Yusuf Bayraktar | 2007 | World Journal of Gastroenterology2007，13，13： | 18 |
| 3 | Increased levels of homocysteine in patients with ulcerative colitis显示文摘AIM: To investigate serum levels of homocysteine (Hcys) and the risk that altered levels carry for thrombosis development in ulcerative colitis (UC) patients. METHODS: 55 UC patients and 45 healthy adults were included. Hcys, vitamin B12 and folic acid levels were measured in both groups. Clinical history and thrombo- embolic events were investigated. RESULTS: The average Hcys level in the UC patients was 13.3 ± 1.93 μmmol/L (range 4.60-87) and was higher than the average Hcys level of the control group which was 11.2 ± 3.58 μmmol/L (range 4.00-20.8) (P < 0.001). Vitamin B12 and folic acid average values were also lower in the UC group (P < 0.001). Whenmultivariate regression analysis was performed, it was seen that folic acid deficiency was the only risk factor for hyperhomocysteinemia. Frequencies of thromboembolic complications were not statistically significantly different in UC and control groups. When those with and without a thrombosis history in the UC group were compared according to Hcys levels, it was seen that there were no statistically significant differences. A negative linear relationship was found between folic acid levels and Hcys. CONCLUSION: We could not find any correlations between Hcys levels and history of prior thromboembolic events. | Sabiye Akbulut Emin Altiparmak Firdevs Topal Ersan Ozaslan Metin Kucukazman Ozlem Yonem | 2010 | World Journal of Gastroenterology2010，16，19： | 13 |
| 4 | Is portal vein cavernous transformation a component of congenital hepatic fibrosis?显示文摘Congenital hepatic fibrosis (CHF) is an autosomal recessive disorder that belongs to the family of fibropolycystic liver diseases. This family includes a spectrum of disorders which are usually found in combination with each other and are usually inherited. Clinically fibropolycystic diseases have three effects being present in different proportions, those of a space occupying lesion, of portal hypertension and of cholangitis. In most patients, the first manifestations of CHF are signs and symptoms related to portal hypertension such as splenomegaly and varices. Portal hypertension in these patients has been attributed to the hypoplasia or compression of the portal vein radicles in the fibrous bands. Cavernous transformation of the portal vein (CTPV) is a relatively rare condition resulting from extrahepatic portal vein obstruction with recanalization or collateral vein formation to bypass the obstruction. It has been found that patients with CHF having an accompanying CTPV have relatively large splenomegaly and suffers more frequent episodes of bleeding from esophageal varices.We believe that CTPV is a congenital component of CHF and also one of the important causative factors of portal hypertension in these patients. | Ozlem Yonem Yusuf Bayraktar | 2007 | World Journal of Gastroenterology2007，13，13： | 9 |
| 5 | Comparison of Two Different Treatment Protocols in Helicobacter pylori Eradication显示文摘 | Isilay Nadir Ozlem Yonem Yasemin Ozin Zeki Mesut Yalin Kilic Orhan Sezgin | 2011 | Southern Medical Journal2011，，2： | 2 |
| 6 | Prophylactic use of lamivudine with chronic immunosuppressive therapy for rheumatologic disorders显示文摘 | Umut Kalyoncu Ozlem Yonem Meral Calguneri Osman Ersoy Omer Karadag Ali Akdogan Sule A Bilgen Sedat Kiraz Ihsan Ertenli Yusuf Bayraktar | 2009 | Rheumatology International2009，，： | 1 |
| 7 | Insulin resistance in nonobese patients with polycystic ovary syndrome显示文摘 | Toprak S Yonem A CakirB | 2001 | Horm Res2001，55，2： | 1 |
| 8 | Nitric oxide and renal func- tions in liver cirrhosis显示文摘 | Turkay C Yonem O Arikan O | 2004 | Turk J Gastroentero2004，15，2： | 1 |
| 9 | Clinical characteristics of Caroli's syndrome显示文摘 | Yonem O Bayraktar Y | 2007 | World J Gastroenterol2007，13，13： | 1 |
| 10 | Duodenal Stromal tumor: A rare and overlooked cause of massive gastrdintegtinal bleeding显示文摘 | Seekin Y Koyuneu A Ozlem Yonem O | 2009 | Turk J Gastroenterol2009，20，2： | 1 |
| 11 | Prophylactic use of lamivudine with chronic immunosuppressive therapy for rheumatologic disorders显示文摘 | Kalyoncu U Yonem O Calguneri M | | 0，，12： | 1 |
| 12 | Characteristic features of 20 patients with Sheehan’s syndrome显示文摘 | Hatice Sebila Dö kmeta&scedil Fatih Kilicli Serdal Korkmaz Ozlem Yonem | 2006 | Gynecological Endocrinology2006，，5： | 1 |
| 13 | Insulin resistance in nonobese patients with polycystic ovary syndrome显示文摘 | Toprak S Yonem A Cakir B | 2001 | Horm Res2001，55，2： | 1 |
| 14 | Nitric oxide and renal functions in liver cirrhosis显示文摘 | Turkay C Yonem O Arikan O | 2004 | Turk J Gastroenterol2004，15，2： | 1 |
| 15 | Clinical characteristics of Caroli's disease显示文摘 | Yonem O Bayraktar Y | | 0，，13： | 1 |
| 16 | Results of stereotactic aspiration in175cases of putaminal hemorrhage显示文摘 | Niizuma H Shiizu Y Yonem T | 1989 | Neurosur-gery1989，24，6： | 1 |
| 17 | Gastric carcinoma and thyroid status显示文摘 | KANDEMIR EG YONEM A NARIN Y | 2004 | J Int Med Res2004，33，： | 1 |
| 18 | Effects of granulocyte-colony stimulating factor in the treatment of diabetic foot infection 显示文摘 | Yonem A Cakir B Guler S | 2001 | Diabetes Obes Metab2001，3，： | 1 |
| 19 | Gastric carcinoma and thyroid status 显示文摘 | Kandemir EG Yonem A Narin Y | 2005 | J Int Med Res2005，33，2： | 1 |
| 20 | Effect of angiotensin-converting enzyme inhibition on experimental hepatic fibrogenesis显示文摘 | TURKAY C YONEM O ARICI S | 2008 | Dig Dis Sci2008，53，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员